The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients. (1st June 2018)

Record Type:
Journal Article
Title:
The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients. (1st June 2018)
Main Title:
The Role of Osimertinib in Treatment Naïve Epidermal Growth Factor Receptor–Mutated Stage IIIB or IV Non–Small-Cell Lung Cancer Patients
Authors:
Uprety, Dipesh
Bista, Amir
Vallatharasu, Yazhini
Arjyal, Lubina
Abstract:
Is Part Of:
Clinical medicine insights. Oncology. Volume 12(2018)
Journal:
Clinical medicine insights. Oncology
Issue:
Volume 12(2018)
Issue Display:
Volume 12, Issue 2018 (2018)
Year:
2018
Volume:
12
Issue:
2018
Issue Sort Value:
2018-0012-2018-0000
Page Start:
Page End:
Publication Date:
2018-06-01
Subjects:
EGFR -- NSCLC -- osimertinib
Oncology -- Periodicals
616.994005
Journal URLs:
https://journals.sagepub.com/home/onc ↗
http://www.uk.sagepub.com/home.nav ↗
DOI:
10.1177/1179554918779585 ↗
Languages:
English
ISSNs:
1179-5549
Deposit Type:
Legaldeposit
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:
9548.xml